期刊文献+

pH、温度和光照等因素对胸腺肽α_1稳定性的影响 被引量:1

Influence of pH,temperature and light on stability of thymosin α_1
原文传递
导出
摘要 目的:考察pH、温度、光照等因素对胸腺肽α1稳定性的影响。方法:采用HPLC法分析胸腺肽α1在不同条件下的含量变化,将浓度变化与时间作线性回归,求得药物在不同pH条件下的降解曲线方程,利用降解速率常数反映出胸腺肽α1在恒温条件下的最适pH。结果:酸、碱、光照及高温均能促进胸腺肽α1的降解,药物的最稳定pH在5~6之间,且在醋酸盐缓冲液中较稳定。结论:温度、pH、光照等因素对胸腺肽α1的稳定性有显著影响。 Objective:To investigate the influence of pH, temperature and light on stability of thymosin α1. Meth- ods:An adjusted HPLC method was employed to determine concentration changes of thymosin α1 with these experi- mental factors mentioned above. The degradation calculations of thymosin α1 under different pH conditions were ob- tained by linear regression analysis between concentration and time, whose slopes indicated the sensitivity of the drug stability to these influencing factors. Result:Acid, alkali, light and high temperature could promote the degra- dation of thymosin α1. Thymosin α1 was stable in the acetate buffer, and achieved the highest stability when pH was between 5 and 6. Conclusion:Temperature, pH, light and other factors have a significant effect on the stability of thymosin α1
机构地区 苏州大学药学院
出处 《药物分析杂志》 CAS CSCD 北大核心 2012年第12期2190-2193,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 胸腺肽Α1 温度 光照 高效液相色谱法 稳定性 PH thymosin α1 temperature light HPLC stability pH
  • 相关文献

参考文献8

二级参考文献88

共引文献82

同被引文献10

  • 1TANIGAWARA Y,KAKU M,TOSUKA K,et al. Population pharmacokinetics and pharmacodynamics of sitafloxacin in pa- tients with community-acquired respiratory tract infections[ J]. J Infect Chemother,2013,19 ( 5 ) :858 - 866.
  • 2SHI GM, CHEN XD,WANG H,et al. Activity of sitanoxacin a- gainst extracellular and intracclluIar Staphylococcus aureus in vitro and in vivo:comparison with levofloxacin and moxifloxacin [ J]. J Antibiot(Tokyo) ,2012,65 ( 5 ) :229 - 236.
  • 3MATSUMOTOT,YAMAGUCHI H,UCHINO K. Efficacy and safety of sitafloxacin in patients with urinary tract infections[ J]. Jpn J Antibiot ,2012,65 (6) :365 - 380.
  • 4MATSUZAKI J,SUZUKI H,NISHIZAWA T,et al. Efficacy of sitailoxacin-based rescue therapy for helicobacter pylori after fail- ures of first-and second-line therapies [ J ]. Antimicrob Agents Chemother,2012,56(3) :1643 - 1645.
  • 5MURAKAMI K, OKIMOTO T,KODAMA M. Sitafloxacin Activity against Helicobacter pylori Isolates, Including Those with gyrA Mutations [ J ]. Antimicrob Agents Chemother, 2009, 53 ( 7 ) : 3097 - 3099.
  • 6AOKI H, OHSHIMA. Y, TANAKA M, et al. High-performance liquid chromatographic determination of the new quinolone anti- bacterial agent DU-6859a in human serum and urine using solid- phase extraction with photolysis-fluorescence detection [ J ]. J Chromatogr B Biomed Appl, 1994,660 ( 2 ) :365 - 374.
  • 7刘晓,陈晓辉,戴锦娜,赵娟娟,刘冰,赵旭,毕开顺.溶液pH、温度和光照等因素对盐酸阿比朵尔稳定性影响的考察[J].药物分析杂志,2009,29(5):833-836. 被引量:3
  • 8柴芸,刘明亮.新氟喹诺酮类抗菌药西他沙星[J].国外医药(抗生素分册),2009,30(6):264-270. 被引量:12
  • 9朱光宇.HPLC法测定西他沙星的含量及有关物质[J].安徽医药,2011,15(12):1512-1513. 被引量:3
  • 10李国庆,胡辛欣,李聪然,王秀坤,张伟新,宋坤改,母立新,游雪甫,杨信怡.西他沙星的体内外抗菌药效学研究[J].中国新药杂志,2013,22(12):1400-1405. 被引量:4

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部